Response to neoadjuvant treatment among rectal cancer patients in a population-based cohort

ConclusionIn this study, patient characteristics were not associated with response to neoadjuvant treatment, and molecular characteristics determined after surgical resection of the tumor were not predictive of pCR or tumor downstaging. Future studies should include molecular biomarkers from biopsy samples before neoadjuvant treatment.
Source: International Journal of Colorectal Disease - Category: Gastroenterology Source Type: research